Freespira named one of Fast Company's 2023 Most Innovative Companies.

Freespira in STAT: Read about Freespira's growth strategy here.

FRE23-04_Device_Illustration-FA highres

Our Company

Freespira, Inc. is the maker of Freespira, the only medication-free, FDA-cleared digital therapeutic treatment proven to significantly reduce or eliminate symptoms of panic disorder, panic attacks and post-traumatic stress disorder in just 28 days.

Health plans, providers, and self-insured employers use the company’s solutions to improve quality of life and to support the appropriate use of valuable healthcare resources.

Freespira Leadership Team

Joseph Perekupka

Joseph Perekupka

Chief Executive Officer
Simon Thomas

Simon Thomas

President
Robert Cuyler, PhD

Robert Cuyler, PhD

Chief Clinical Officer
Camille McMullen

Camille McMullen

Vice President, Government Relations
Sarah Koenig

Sarah Koenig

Vice President, Marketing
Michelle Russell

Michelle Russell

Vice President, Care Operations and Client Success

Board of Directors

Russell Siegelman

Russell Siegelman

Board Chairperson
Stephen Bruso_B&W

Stephen Bruso

Board Member
Debra Reisenthel

Debra Reisenthel

Board Member and Founding CEO
Ned Sheetz

Ned Sheetz

Board Member
Steve Schwartz

Steve Schwartz

Board Member

Our Advisors

Hansa Bhargava, MD

Hansa Bhargava, MD

Woody Myers

Dr. Woodrow Myers

Donald Jones

Donald Jones

Amar Kendale

Amar Kendale

Richard Montwill

Richard Montwill

The Honorable David Shulkin, MD

The Honorable David Shulkin, MD

Alan H. Spiro, MD, MBA

Alan H. Spiro, MD, MBA

Michael Telch, PhD

Michael Telch, PhD

Solomé Tibebu

Solomé Tibebu